SPECTRAL CAPITAL Corp (FCCN): M&A transaction — Spectral Capital closes crwdunit acquisition for 3.75M shares; total shares outstanding 71.7M

SPECTRAL CAPITAL Corp

Acquired 100% of crwdunit, Inc. in exchange for 3,750,000 newly issued shares of Spectral common stock.
Deal valued at $15M; stakeholders receive 1 share of Spectral for every $4 invested in crwdunit.
Post-closing common shares outstanding: 71,742,516; preferred Series Quantum shares: 1,000,000 issued and outstanding.
Assets include quantum-forward edge and hybrid computing IP; audited financials to be filed by amendment.
Spectral trades on OTCQB under ticker FCCN; Chairman Sean Michael Brehm and CEO Jenifer Osterwalder cited growth ambitions.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

SPECTRAL CAPITAL Corp completed an acquisition involving Crowdpoint Technologies, Inc. / Crwdunit Inc. for $15,000,000, paid through the issuance of the Exchange Shares (closed 2024-12-10).

Action: acquisition
Counterparty: Crowdpoint Technologies, Inc. / Crwdunit Inc.
Consideration: $15,000,000, paid through the issuance of the Exchange Shares
Closing: 2024-12-10

Exact text from the filing

(the “ Common Stock ”). The Exchange Agreement provided that the Company would acquire 100% of the issued and outstanding shares of the Target for a total purchase price of $15,000,000, paid through the issuance of the Exchange Shares. The closing of the transaction (the “ Closing ”) was expected to occur by December 10, 2024 and was subject to the satisfaction

View on SEC.gov

9 m&a transactions filed in the last 30 days. Browse all m&a transactions →

SPECTRAL CAPITAL Corp filing history →

Source: SEC EDGAR

accession 0001096906-24-002251

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.